| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | MP470 | GDSC1000 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | cediranib | CTRPv2 | pan-cancer | AAC | 0.049 | 0.4 |
| mRNA | Fumonisin B1 | CTRPv2 | pan-cancer | AAC | 0.034 | 0.4 |
| mRNA | fulvestrant | CTRPv2 | pan-cancer | AAC | -0.07 | 0.4 |
| mRNA | SB-431542 | CTRPv2 | pan-cancer | AAC | -0.034 | 0.4 |
| mRNA | BRD-K09587429 | CTRPv2 | pan-cancer | AAC | 0.036 | 0.4 |
| mRNA | Bexarotene | GDSC1000 | pan-cancer | AAC | 0.033 | 0.4 |
| mRNA | Dasatinib | GDSC1000 | pan-cancer | AAC | 0.047 | 0.4 |
| mRNA | KU-55933 | CTRPv2 | pan-cancer | AAC | -0.032 | 0.4 |
| mRNA | necrostatin-7 | CTRPv2 | pan-cancer | AAC | 0.033 | 0.4 |